During the past decade, Medisprof SRL conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 19 clinical trials were completed, i.e. on average, 67.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 12 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medisprof SRL" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Pfizer" with 4 trials sponsored, "Amgen" with 3 trials sponsored, "BeiGene" with 2 trials sponsored and "Biocad" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medisprof SRL" #1 collaborator was "BeiGene" with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Caris Life Sciences" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Medisprof SRL" are "Gastric Cancer" (4 trials), "Non-Small Cell Lung Cancer" (2 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Ovarian Cancer" (2 trials) and "Renal Cell Carcinoma" (2 trials). Many other conditions were trialed in "Medisprof SRL" in a lesser frequency.

Most popular intervention types in "Medisprof SRL" are "Drug" (37 trials), "Biological" (5 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (6 trials), "Paclitaxel" (6 trials), "Cisplatin" (5 trials) and "Capecitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medisprof SRL" are 33 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medisprof SRL". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Medisprof SRL, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Medisprof SRL, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".